06:59 AM EST, 02/18/2025 (MT Newswires) -- GeneDx Holdings ( WGS ) reported adjusted net income Tuesday of $16.8 million compared with an adjusted net loss of $17.8 million a year earlier.

Two analysts surveyed by FactSet expected $1.6 million.

Revenue for the quarter ended Dec. 31 was $95.6 million, up from $58.1 million a year earlier.

Analysts surveyed by FactSet expected $82.2 million.

For the full year, GeneDx ( WGS ) expects revenue between $350 million and $360 million, with growth in exome/genome volume and revenue of at least 30%.

Analysts surveyed by FactSet expect $338.8 million.

The company's shares were up more than 25% in recent Tuesday premarket activity.